deutetrabenazin
Deutetrabenazin is a medication used to treat restless legs syndrome (RLS), a neurological disorder characterized by an irresistible urge to move the legs, often accompanied by uncomfortable sensations. It is also used to treat periodic limb movement disorder (PLMD), a condition where people experience repetitive, involuntary movements in their limbs, typically during sleep. Deutetrabenazin works by increasing the levels of dopamine in the brain, which helps to reduce the symptoms of RLS and PLMD.
The medication is available in tablet form and is typically taken once or twice a day, depending
Deutetrabenazin was first approved for medical use in the United States in 2004. It is manufactured by